CDMO Services
Cell & Gene Therapy
Partner focused. Patient driven.
Your global provider of tailored CGT solutions.
C3i has built a one-stop shop in the development chain of Cell & Gene Therapy.
We work closely with our clients to manufacture products destined for patients all over the world. C3i prides itself on delivering, on time, quality results on behalf of its clients and for patients, advanced cell and gene products that meet regulatory requirements around the world.
Our Purpose
We work with our clients to ensure we put patients first. We are driven to perform our best knowing that the cells in our hands may be the patient's only chance at survival.
Our People
We are dedicated and highly trained personnel with over 15 years of experience in cell therapy and cGMP manufacturing.
Our Facility
C3i is the only fully validated cGMP center in Canada compliant with FDA, EMA, and Health Canada regulations with commercial capacity.
Fully integrated in-house and on-site services to ensure seamless communication between all parties
We are a CDMO that develops, translates, and manufactures complex cell and gene therapies with a very high success rate. Our strength lies in working with our partners to advance the industry’s ability to bring cell and gene therapy research to market.
We are an extension of your team
C3i works as part of your team proudly blurring the lines between “you“ and “us” to the most desirable “we.” We are the CDMO for cell and gene therapy that fills the gap between your research and innovative patient therapies.
Read the latest news
-
Apr 10, 2026C3i at the 4th CellCAN Strategic Forum 2026 in Laval
Read MoreFrom April 7 to 9, 2026, C3i took part in the 4th Pan-Canadian Strategic Forum on Cell and Gene Therapies, organized by CellCAN at the Sheraton Laval & Convention Center. The event brought together key players in the sector, including scientists, innovators, and partners from the cell and gene therapy biomanufacturing ecosystem, around a […]
-
Mar 31, 2026C3i Attended the 2026 Summit4CI
Read MoreFrom March 29 to 31, 2026, C3i participated in the Summit for Cancer Immunotherapy (Summit4CI), organized by BioCanRx in Vancouver. This annual event brings together scientists, clinicians, industry leaders, and patient advocates committed to advancing immuno-oncology. At the event, Jamie Sharp, Director of Business Development at C3i, represented the organization to engage with the […]
-
Mar 11, 2026Preparing for Regulatory Inspection in Cell and Gene Therapy Manufacturing
Read MoreRegulatory inspections represent a critical validation of manufacturing quality systems in cell and gene therapy. These inspections assess not only whether procedures exist, but whether they are effectively implemented and consistently followed. For advanced therapy manufacturers, inspection readiness reflects the strength, maturity, and reliability of the entire Quality Assurance framework. At C3i, inspection readiness begins […]
Make great strides in your career at C3i
C3i offers a wide range of opportunities for you to contribute to our mission of advancing cell and gene therapy.